USA - NASDAQ:ASTH - US03763A2078 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to ASTH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-01 | Barclays | Initiate | Equal-Weight |
| 2025-03-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-04 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-03 | Baird | Maintains | Outperform -> Outperform |
| 2025-02-20 | Stifel | Maintains | Buy -> Buy |
| 2025-01-13 | Truist Securities | Maintains | Buy -> Buy |
| 2024-11-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-14 | TD Cowen | Initiate | Buy |
| 2024-10-11 | Keybanc | Initiate | Sector Weight |
| 2024-10-03 | BTIG | Maintains | Buy -> Buy |
| 2024-08-15 | Baird | Maintains | Outperform -> Outperform |
| 2024-08-09 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-01 | Stifel | Maintains | Buy -> Buy |
| 2024-07-11 | Truist Securities | Upgrade | Hold -> Buy |
| 2024-06-27 | Stifel | Maintains | Buy -> Buy |
| 2024-05-30 | Baird | Initiate | Outperform |
| 2024-05-08 | Stifel | Maintains | Buy -> Buy |
| 2024-03-01 | Truist Securities | Maintains | Hold -> Hold |
16 analysts have analysed ASTH and the average price target is 45.9 USD. This implies a price increase of 37.84% is expected in the next year compared to the current price of 33.3.
The consensus rating for ASTRANA HEALTH INC (ASTH) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.